Caractéristiques pharmacologiques de la rosuvastatine, un nouvel antagoniste de l'HMG-CoA réductase
Thérapie, 58 2 (2003) 113-121
Published online: 2007-03-01
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Design, Synthesis, Biological Evaluation, DFT Calculations, and Molecular Docking Investigations of 99mTc‐Rosuvastatin as a Promising Radiopharmaceutical for Liver Targeting
Moustapha Eid Moustapha, El Hassane Anouar, Hend Fayez and Mahmood AhmedJournal of Chemistry 2025 (1) (2025)
https://doi.org/10.1155/joch/6685000
A new animal model of cardiorenal syndrome could be established by inducing heart failure through coronary artery ligation in spontaneously hypertensive rats
Biye Zhou, Jinbao Zhao and Dong LiScientific Reports 14 (1) (2024)
https://doi.org/10.1038/s41598-024-69662-3
Bioconversion of lovastatin to simvastatin by Streptomyces carpaticus toward the inhibition of HMG‐CoA activity
Janani Balraj, Thandeeswaran Murugesan, Anand Raj Dhanapal, Vidhya Kalieswaran, Karunyadevi Jairaman, Govindaraju Archunan and Angayarkanni JayaramanBiotechnology and Applied Biochemistry 70 (3) 1162 (2023)
https://doi.org/10.1002/bab.2429
Bioconversion of lovastatin to a novel statin by Amycolatopsis sp.
Bin Zhuge, Hui Ying Fang, Hai Yu, et al.Applied Microbiology and Biotechnology 79 (2) 209 (2008)
https://doi.org/10.1007/s00253-008-1430-5
Myalgia, hyper‐CK‐aemia, and hypocoagulability in a patient under rosuvastatin and warfarin
J. Finsterer and C. StöllbergerEuropean Journal of Neurology 12 (8) 660 (2005)
https://doi.org/10.1111/j.1468-1331.2005.01027.x